Impact of the introduction of CDK4/6 inhibitors on treatment duration in patients with HR+, HER2-advanced breast cancer: Final analysis of TreatER plus ight, a Canadian prospective, real-world, observational study

被引：0

作者：

Doyle, Catherine

Lohmann, Ana Elisa

Iqbal, Nayyer

Henning, Jan-Willem

Kulkarni, Swati

Califaretti, Nadia

Hilton, John

Ferrario, Cristiano

Bouganim, Nathaniel

Mates, Mihaela

Guillemette, Stephanie

Leite, Ricardo

Chia, Stephen

机构：

来源：

关键词：

D O I：

10.1158/1538-7445.SABCS23-PO2-17-01

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO2-17-01

引用

页数：3